Circadian rhythms in liver metabolism and disease

Acta Pharmaceutica Sinica B

Volumn 5, Issue 2, 2015, Pages 113-122

  Ferrell, Jessica M ^a   Chiang, John Y L ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Circadian rhythm; Liver; Metabolic syndrome; Type 2 diabetes

Indexed keywords

BILE ACID; CASEIN KINASE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; DNA; FARNESOID X RECEPTOR; GLUCOSE; LIPID;

BILE ACID BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; DNA METHYLATION; DYSLIPIDEMIA; EPIGENETICS; FEEDBACK SYSTEM; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; HUMAN; INCIDENCE; JET LAG; LIPID HOMEOSTASIS; LIVER DISEASE; LIVER METABOLISM; METABOLIC SYNDROME X; MOUSE; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SHIFT WORKER; SLEEP DISORDER;

EID: 84947202028     PISSN: 22113835     EISSN: 22113843     Source Type: Journal    
DOI: 10.1016/j.apsb.2015.01.003     Document Type: Review

References (118)

1. Aschoff J. Circadian rhythms in man. Science 1965, 148:1427-1432.
2. Pittendrigh CS. Circadian rhythms and the circadian organization of living systems. Cold Spring Harb Symp Quant Biol 1960, 25:159-184.
3. Cassone VM, Speh JC, Card JP, Moore RY. Comparative anatomy of the mammalian hypothalamic suprachiasmatic nucleus. J Biol Rhythms 1988, 3:71-91.
4. Moore RY, Card JP. Visual pathways and the entrainment of circadian rhythms. Ann NY Acad Sci 1985, 453:123-133.
5. Mrosovsky N. Locomotor activity and non-photic influences on circadian clocks. Biol Rev 1996, 71:343-372.
6. Harmer SL, Panda S, Kay SA. Molecular bases of circadian rhythms. Annu Rev Cell Dev Biol 2001, 17:215-253.
7. Guillaumond F, Dardente H, Giguère V, Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 2005, 20:391-403.
8. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night-shift work and risk of colorectal cancer in the Nurses[U+05F3] health study. JNCI J Natl Cancer Inst 2003, 95:825-828.
9. Zhen Lu W, Ann Gwee K, Yu Ho K. Functional bowel disorders in rotating shift nurses may be related to sleep disturbances. Eur J Gastroenterol Hepatol 2006, 18:623-627.
10. Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. Circadian rhythms and cardiovascular health. Sleep Med Rev 2012, 16:151-166.
11. Konturek PC, Brzozowski T, Konturek SJ. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol 2011, 62:139-150.
12. Nojkov B, Rubenstein JH, Chey WD, Hoogerwerf WA. The impact of rotating shift work on the prevalence of irritable bowel syndrome in nurses. Am J Gastroenterol 2010, 105:842-847.
13. Scheer FAJL, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA 2009, 106:4453-4458.
14. Pietroiusti A, Neri A, Somma G, Coppeta L, Iavicoli I, Bergamaschi A, et al. Incidence of metabolic syndrome among night-shift healthcare workers. Occup Environ Med 2010, 67:54-57.
15. Esquirol Y, Bongard V, Mabile L, Jonnier B, Soulat JM, Perret B. Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms. Chronobiol Int 2009, 26:544-559.
16. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. JNCI J Natl Cancer Inst 2001, 93:1557-1562.
17. Grundy A, Richardson H, Burstyn I, Lohrisch C, SenGupta SK, Lai AS, et al. Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med 2013, 70:831-838.
18. Straif K, Baan R, Grosse Y, Secretan B, Ghissassi FE, Bouvard V, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007, 8:1065-1066.
19. Lecarpentier Y, Claes V, Duthoit G, Hébert JL. Circadian rhythms, Wnt/β-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction. Front Physiol 2014, 5:429.
20. Yoshitane H, Ozaki H, Terajima H, Du NH, Suzuki Y, Fujimori T, et al. CLOCK-controlled polyphonic regulation of circadian rhythms through canonical and noncanonical E-boxes. Mol Cell Biol 2014, 34:1776-1787.
21. Chiang JY. Regulation of bile acid synthesis. Front Biosci 1998, 3:d176-d193.
22. Yamada M, Nagatomo J, Setoguchi Y, Kuroki N, Higashi S, Setoguchi T. Circadian rhythms of sterol 12α-hydroxylase, cholesterol 7α-hydroxylase and DBP involved in rat cholesterol catabolism. Biol Chem 2000, 381:1149-1153.
23. Kovář J, Leníček M, Zimolová M, Vítek L, Jirsa M, Piťha J. Regulation of diurnal variation of cholesterol 7α-hydroxylase (CYP7A1) activity in healthy subjects. Physiol Res 2010, 59:233-238.
24. Noshiro M, Usui E, Kawamoto T, Kubo H, Fujimoto K, Furukawa M, et al. Multiple mechanisms regulate circadian expression of the gene for cholesterol 7α-hydroxylase (Cyp7α), a key enzyme in hepatic bile acid biosynthesis. J Biol Rhythms 2007, 22:299-311.
25. Edwards PA, Muroya H, Gould RG. In vivo demonstration of the circadian thythm of cholesterol biosynthesis in the liver and intestine of the rat. J Lipid Res 1972, 13:396-401.
26. Gälman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 2005, 129:1445-1453.
27. Li T, Matozel M, Boehme S, Kong B, Nilsson LM, Guo G, et al. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology 2011, 53:996-1006.
28. Ma K, Xiao R, Tseng HT, Shan L, Fu L, Moore DD. Circadian dysregulation disrupts bile acid homeostasis. PLoS One 2009, 4:e6843.
29. Duez H, van der Veen JN, Duhem C, Pourcet B, Touvier T, Fontaine C, et al. Regulation of bile acid synthesis by the nuclear receptor REV-ERBα. Gastroenterology 2008, 135:689-698.
30. Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure DB, et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ. Nat Struct Mol Biol 2007, 14:1207-1213.
31. Delerive P, Chin WW, Suen CS. Identification of Reverbα as a novel RORα target gene. J Biol Chem 2002, 277:35013-35018.
32. Raspè E, Mautino G, Duval C, Fontaine C, Duez H, Barbier O, et al. Transcriptional regulation of human REV-ERBα gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor α. J Biol Chem 2002, 277:49275-49281.
33. Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, et al. REV-ERBα, a heme sensor that coordinates metabolic and circadian pathways. Science 2007, 318:1786-1789.
34. Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, et al. Regulation of circadian behaviour and metabolism by REV-ERBα and REV-ERBβ. Nature 2012, 485:123-127.
35. Solt LA, Wang YJ, Banerjee S, Hughes T, Kojetin DJ, Lundasen T, et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 2012, 485:62-68.
36. Ruiter M, La Fleur SE, van Heijningen C, van der Vliet J, Kalsbeek A, Buijs RM. The daily rhythm in plasma glucagon concentrations in the rat is modulated by the biological clock and by feeding behavior. Diabetes 2003, 52:1709-1715.
37. Boden G, Ruiz J, Urbain JL, Chen X. Evidence for a circadian rhythm of insulin secretion. Am J Physiol 1996, 271:E246-E252.
38. La Fleur SE, Kalsbeek A, Wortel J, Buijs RM. A suprachiasmatic nucleus generated rhythm in basal glucose concentrations. J Neuroendocrinol 1999, 11:643-652.
39. La Fleur SE, Kalsbeek A, Wortel J, Fekkes ML, Buijs RM. A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes 2001, 50:1237-1243.
40. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon EL, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005, 308:1043-1045.
41. Chaves I, van der Horst GT, Schellevis R, Nijman RM, Koerkamp MG, Holstege FC, et al. Insulin-FOXO3 signaling modulates circadian rhythms via regulation of clock transcription. Curr Biol 2014, 24:1248-1255.
42. Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010, 466:627-631.
43. Sadacca LA, Lamia KA, deLemos AS, Blum B, Weitz CJ. An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice. Diabetologia 2011, 54:120-124.
44. Lamia KA, Storch KF, Weitz CJ. Physiological significance of a peripheral tissue circadian clock. Proc Natl Acad Sci USA 2008, 105:15172-15177.
45. Mayer KH, Stamler J, Dyer A, Freinkel N, Stamler R, Berkson DM, et al. Epidemiologic findings on the relationship of time of day and time since last meal to glucose tolerance. Diabetes 1976, 25:936-943.
46. Aparicio NJ, Puchulu FE, Gagliardino JJ, Ruiz M, Llorens JM, Ruiz J, et al. Circadian variation of the blood glucose, plasma insulin and human growth hormone levels in response to an oral glucose load in normal subjects. Diabetes 1974, 23:132-137.
47. Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997, 18:716-738.
48. Shih KC, Hsieh SH, Kwok CF, Hwu CM, Hsieh PS, Ho LT. Effect of growth hormone on dawn phenomenon in patients with type 2 diabetes. Growth Factors 2013, 31:66-73.
49. Porcellati F, Lucidi P, Bolli GB, Fanelli CG. Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. Diabetes Care 2013, 36:3860-3862.
50. Kohsaka A, Laposky AD, Ramsey KM, Estrada C, Joshu C, Kobayashi Y, et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 2007, 6:414-421.
51. Muoio DM, Lynis Dohm G. Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab 2002, 16:653-666.
52. Kalsbeek A, Fliers E, Romijn JA, la Fleur SE, Wortel J, Bakker O, et al. The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology 2001, 142:2677-2685.
53. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996, 97:1344-1347.
54. Figlewicz DP, MacDonald Naleid A, Sipols AJ. Modulation of food reward by adiposity signals. Physiol Behav 2007, 91:473-478.
55. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006, 51:801-810.
56. Banks AS, Davis SM, Bates SH, Myers MG. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 2000, 275:14563-14572.
57. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997, 46:313-316.
58. Pallett AL, Morton NM, Cawthorne MA, Emilsson V. Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets. Biochem Biophys Res Commun 1997, 238:267-270.
59. Huang W, Dedousis N, Bhatt BA, O'Doherty RM. Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. J Biol Chem 2004, 279:21695-21700.
60. Meinders AE, Toornvliet AC, Pijl H. Leptin. Neth J Med 1996, 49:247-252.
61. Ando H, Kumazaki M, Motosugi Y, Ushijima K, Maekawa T, Ishikawa E, et al. Impairment of peripheral circadian clocks precedes metabolic abnormalities in ob/ob mice. Endocrinology 2011, 152:1347-1354.
62. Ishikawa-Kobayashi E, Ushijima K, Ando H, Maekawa T, Takuma M, Furukawa Y, et al. Reduced histone H3K9 acetylation of clock genes and abnormal glucose metabolism in ob/ob mice. Chronobiol Int 2012, 29:982-993.
63. Mauvoisin D, Dayon L, Gachon F, Kussmann M. Proteomics and circadian rhythms: it[U+05F3]s all about signaling!. Proteomics 2015, 15:310-317.
64. Welberg L. Circadian rhythms: methylation mediates clock plasticity. Nat Rev Neurosci 2014, 15:206.
65. Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J 2012, 31:1405-1426.
66. Milagro FI, Gómez-Abellán P, Campión J, Martínez JA, Ordovás JM, Garaulet M. CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol Int 2012, 29:1180-1194.
67. Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, Nakahata Y, et al. CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature 2007, 450:1086-1090.
68. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006, 125:497-508.
69. Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 2011, 331:1315-1319.
70. +-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134:329-340.
71. Reddy AB, Karp NA, Maywood ES, Sage EA, Deery M, O'Neill JS, et al. Circadian orchestration of the hepatic proteome. Curr Biol 2006, 16:1107-1115.
72. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPER2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001, 291:1040-1043.
73. Vanselow K, Kramer A. Role of phosphorylation in the mammalian circadian clock. Cold Spring Harb Symp Quant Biol 2007, 72:167-176.
74. Masri S, Patel VR, Eckel-Mahan KL, Peleg S, Forne I, Ladurner AG, et al. Circadian acetylome reveals regulation of mitochondrial metabolic pathways. Proc Natl Acad Sci USA 2013, 110:3339-3344.
75. Fonken LK, Nelson RJ. The effects of light at night on circadian clocks and metabolism. Endocr Rev 2014, 35:648-670.
76. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses[U+05F3] health study. JNCI J Natl Cancer Inst 2001, 93:1563-1568.
77. Truong T, Liquet B, Menegaux F, Plancoulaine S, Laurent-Puig P, Mulot C, et al. Breast cancer risk, nightwork, and circadian clock gene polymorphisms. Endocr Relat Cancer 2014, 21:629-638.
78. Hill S, Blask D, Xiang S, Yuan L, Mao L, Dauchy R, et al. Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. J Mammary Gland Biol Neoplasia 2011, 16:235-245.
79. Puttonen S, Härmä M, Hublin C. Shift work and cardiovascular disease-pathways from circadian stress to morbidity. Scand J Work Environ Health 2010, 36:96-108.
80. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 2001, 58:747-752.
81. Knutsson A. Health disorders of shift workers. Occup Med 2003, 53:103-108.
82. Gale JE, Cox HI, Qian J, Block GD, Colwell CS, Matveyenko AV. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. J Biol Rhythms 2011, 26:423-433.
83. Fonken LK, Workman JL, Walton JC, Weil ZM, Morris JS, Haim A, et al. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci USA 2010, 107:18664-18669.
84. Salgado-Delgado R, Angeles-Castellanos M, Saderi N, Buijs RM, Escobar C. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinology 2010, 151:1019-1029.
85. Barclay JL, Husse J, Bode B, Naujokat N, Meyer-Kovac J, Schmid SM, et al. Circadian desynchrony promotes metabolic disruption in a mouse model of shiftwork. PLoS One 2012, 7:e37150.
86. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004, 1:e62.
87. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850.
88. Omisade A, Buxton OM, Rusak B. Impact of acute sleep restriction on cortisol and leptin levels in young women. Physiol Behav 2010, 99:651-656.
89. Crispim CA, Waterhouse J, Dâmaso AR, Zimberg IZ, Padilha HG, Oyama LM, et al. Hormonal appetite control is altered by shift work: a preliminary study. Metabolism 2011, 60:1726-1735.
90. Davis S, Mirick DK, Chen C, Stanczyk FZ. Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev 2012, 21:609-618.
91. Manenschijn L, van Kruysbergen RG, de Jong FH, Koper JW, van Rossum EF. Shift work at young age is associated with elevated long-term cortisol levels and body mass index. J Clin Endocrinol Metab 2011, 96:E1862-E1865.
92. Alonso-Vale MIC, Andreotti S, Peres SB, Anhê GF, das Neves Borges-Silva C, Neto JC, et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 2005, 288:E805-E812.
93. Wabitsch M, Bo Jensen P, Blum WF, Christoffersen CT, Englaro P, Heinze E, et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996, 45:1435-1438.
94. Leproult R, Holmbäck U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014, 63:1860-1869.
95. Damiola F, Minh NL, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev 2000, 14:2950-2961.
96. Mistlberger RE. Food-anticipatory circadian rhythms: concepts and methods. Eur J Neurosci 2009, 30:1718-1729.
97. Escobar C, Cailotto C, Angeles-Castellanos M, Delgado RS, Buijs RM. Peripheral oscillators: the driving force for food-anticipatory activity. Eur J Neurosci 2009, 30:1665-1675.
98. Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong EA, Gill S, et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab 2012, 15:848-860.
99. Wu N, Yin L, Hanniman EA, Joshi S, Lazar MA. Negative feedback maintenance of heme homeostasis by its receptor, REV-ERBα. Genes Dev 2009, 23:2201-2209.
100. Arble DM, Bass J, Laposky AD, Vitaterna MH, Turek FW. Circadian timing of food intake contributes to weight gain. Obesity 2009, 17:2100-2102.
101. Bodosi B, Gardi J, Hajdu I, Szentirmai E, Obal F, Krueger JM. Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1071-R1079.
102. Bray MS, Ratcliffe WF, Grenett MH, Brewer RA, Gamble KL, Young ME. Quantitative analysis of light-phase restricted feeding reveals metabolic dyssynchrony in mice. Int J Obes 2013, 37:843-852.
103. Arble DM, Vitaterna MH, Turek FW. Rhythmic leptin is required for weight gain from circadian desynchronized feeding in the mouse. PLoS One 2011, 6:e25079.
104. Sherman H, Genzer Y, Cohen R, Chapnik N, Madar Z, Froy O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J 2012, 26:3493-3502.
105. Vollmers C, Gill S, DiTacchio L, Pulivarthy SR, Le HD, Panda S. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proc Natl Acad Sci USA 2009, 106:21453-21458.
106. Adamovich Y, Rousso-Noori L, Zwighaft Z, Neufeld-Cohen A, Golik M, Kraut-Cohen J, et al. Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides. Cell Metab 2014, 19:319-330.
107. Rothschild J, Hoddy KK, Jambazian P, Varady KA. Time-restricted feeding and risk of metabolic disease: a review of human and animal studies. Nutr Rev 2014, 72:308-318.
108. Plakogiannis R, Cohen H. Optimal low-density lipoprotein cholesterol lowering-morning versus evening statin administration. Ann Pharmacother 2007, 41:106-110.
109. Jones PJ, Schoeller DA. Evidence for diurnal periodicity in human cholesterol synthesis. J Lipid Res 1990, 31:667-673.
110. Tomalik-Scharte D, Suleiman AA, Frechen S, Kraus D, Kerkweg U, Rokitta D, et al. Population pharmacokinetic analysis of circadian rhythms in hepatic CYP3A activity using midazolam. J Clin Pharmacol 2014, 54:1162-1169.
111. Košir R, Španinger K, Rozman D. Circadian events in human diseases and in cytochrome P450-related drug metabolism and therapy. IUBMB Life 2013, 65:487-496.
112. Gachon F, Olela FF, Schaad O, Descombes P, Schibler U. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab 2006, 4:25-36.
113. Akhtar RA, Reddy AB, Maywood ES, Clayton JD, King VM, Smith AG, et al. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol 2002, 12:540-550.
114. Zhang YKJ, Yeager RL, Klaassen CD. Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab Dispos 2009, 37:106-115.
115. Kang HS, Angers M, Beak JY, Wu XY, Gimble JM, Wada T, et al. Gene expression profiling reveals a regulatory role for RORα and RORγ in phase I and phase II metabolism. Physiol Genomics 2007, 31:281-294.
116. Ou Z, Shi X, Gilroy RK, Kirisci L, Romkes M, Lynch C, et al. Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORα and RORγ and its potential relevance to human liver diseases. Mol Endocrinol 2013, 27:106-115.
117. Lévi F, Giacchetti S, Zidani R, Brezault-Bonnet C, Tigaud JM, Goldwasser F, et al. Chronotherapy of colorectal cancer metastases. Hepatogastroenterology 2001, 48:320-322.
118. Harris BE, Song R, Soong SJ, Diasio RB. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res 1990, 50:197-201.